The growth hormone–releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line
To access this article, please choose from the options below
M.A. has nothing to disclose. C.G. has nothing to disclose. F.S. has nothing to disclose. F.D. has nothing to disclose. E.D. has nothing to disclose. M.C. has nothing to disclose. E.G. has nothing to disclose. R.G. has nothing to disclose.
Supported by grants from the Regione Piemonte (2006 and 2008 to E.G.; 2008 to R.G.) and the University of Turin (2006 to E.G; 2007 and 2008 to E.G. and R.G.) and by Ginteam (Turin, Italy).
PII: S0015-0282(09)00763-8
doi:10.1016/j.fertnstert.2009.03.093
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

